An indirect ELISA is a lab technique that detects specific antibodies in a sample by using two layers of antibodies instead of one. It works by coating a plate with a known antigen, adding the sample to see if antibodies bind to it, then adding a second enzyme-linked antibody that produces a measurable color change. This two-antibody approach makes indirect ELISA more sensitive than its simpler cousin, the direct ELISA, and it’s one of the most widely used formats in both research and clinical diagnostics.
How the Indirect ELISA Works
The process follows a layered logic. You start with a known antigen (the protein or molecule you want to test against) and end with a color change you can measure. Each layer builds on the one before it, and wash steps in between remove anything that hasn’t bound tightly.
Here’s the sequence:
- Coating: A known antigen is applied to the wells of a plastic plate and left to incubate, typically for one to two hours at 37°C or overnight at 4°C. The antigen sticks to the plastic surface.
- Blocking: A protein solution (often bovine serum albumin or casein) is added to fill any empty spots on the plate where the antigen didn’t stick. This prevents other proteins from binding to the bare plastic later, which would create false signals.
- Primary antibody: The sample being tested (blood serum, plasma, or another fluid) is added. If the sample contains antibodies that recognize the coated antigen, they bind to it. This primary antibody is unlabeled, meaning it carries no enzyme or tag.
- Secondary antibody: After washing away unbound material, a second antibody is added. This one is conjugated to an enzyme and is designed to recognize and bind to the primary antibody. It essentially “finds” any primary antibody that stuck to the antigen.
- Substrate and detection: A chemical substrate is added that the enzyme converts into a colored product. The intensity of the color corresponds to how much antibody was present in the original sample.
Between every major step, the plate is washed with a buffer solution to remove anything that hasn’t bound specifically. These washes are critical for keeping background noise low and results reliable.
Why Two Antibodies Instead of One
The key difference between a direct and indirect ELISA is that extra antibody layer. In a direct ELISA, a single enzyme-labeled antibody binds straight to the antigen. In an indirect ELISA, the primary antibody binds the antigen, and then multiple secondary antibodies can pile onto that primary antibody. This creates a signal amplification effect: more enzyme molecules end up at each binding site, producing a stronger color change and making it easier to detect low concentrations of antibody.
The secondary antibody also adds practical flexibility. Because it targets the species of the primary antibody (for example, “anti-mouse” or “anti-human”), a single enzyme-conjugated secondary antibody can be paired with many different primary antibodies from the same species. Labs don’t need to buy a separately labeled version of every primary antibody they use, which saves significant cost and simplifies inventory.
Enzymes and Color Detection
The enzyme attached to the secondary antibody is what makes the result visible. The two most common enzyme labels are horseradish peroxidase (HRP) and alkaline phosphatase (AP), chosen because they have a wide range of available substrates.
For HRP, the most popular substrate is TMB, which produces a blue color. Other options yield green or yellow-orange products. For alkaline phosphatase, a substrate called PNPP produces a yellow product. In all cases, the plate is read by a spectrophotometer that measures the color intensity in each well, converting it to a numerical value. Some labs use chemiluminescent substrates instead of colorimetric ones, where the enzyme generates light rather than color, allowing detection of even smaller quantities.
How Long the Assay Takes
A complete indirect ELISA typically takes several hours to a full day, depending on incubation choices. The antigen coating step alone requires one to two hours at 37°C, or it can be done overnight at 4°C for convenience. Sample incubation runs one to two hours. The secondary antibody incubation adds roughly another hour. Substrate development is fast by comparison, often just three to five minutes. Factor in the multiple wash steps and plate preparation, and most protocols run about four to six hours of active bench time when using room-temperature incubations, or can be spread across two days if overnight coating is preferred.
Common Clinical and Research Uses
Indirect ELISA is particularly well suited for detecting whether someone has been exposed to an infectious agent, because it directly measures the antibodies a person’s immune system produced in response. HIV screening is one of the most prominent applications. Indirect ELISA tests targeting HIV antibodies have reported sensitivity of 100% and specificity of 99.5% in clinical evaluations, making them a reliable first-line screening tool. The same approach is used for detecting antibodies against hepatitis B, hepatitis C, and SARS-CoV-2.
Beyond infectious disease, indirect ELISA is used in autoimmune disease testing (detecting self-targeting antibodies), allergy testing, vaccine development (measuring immune responses), and food safety monitoring. Its flexibility with different primary antibodies makes it adaptable to almost any target where antibody detection is the goal.
Signal Amplification Compared to Direct ELISA
Direct ELISA has limited sensitivity because each antigen-antibody binding event produces signal from only one enzyme molecule. Indirect ELISA overcomes this because multiple secondary antibodies can bind to a single primary antibody, multiplying the number of enzyme molecules at each site. This amplification is the main reason labs choose indirect over direct formats when detecting low-abundance targets. The tradeoff is an extra incubation and wash step, adding time and slightly more complexity to the protocol.
Sources of Error and Background Noise
The most common problem in indirect ELISA is non-specific binding, where proteins in the sample or the secondary antibody stick to the plate in places they shouldn’t. This creates background noise that can obscure real results or produce false positives. The blocking step is the primary defense against this, but not all blockers perform equally.
BSA is the most commonly used blocking agent, but research has shown it has weaknesses. BSA binds weakly to plastic plates and can be partially washed away during subsequent steps. One study found that 14% of BSA was displaced from the well surface after serum incubation. BSA can also cross-react with other assay components, further muddying results. Casein has proven more effective in many cases, reducing non-specific binding by 86% compared to 46% for BSA in direct comparisons. Casein binds more tightly to plastic and resists displacement, and a concentration of just 1% is generally enough for effective blocking.
Cross-reactivity from the secondary antibody is another concern unique to indirect ELISA. Because the secondary antibody targets an entire class of antibodies from a given species, it can sometimes bind to antibodies in the sample that aren’t the primary detection antibody. Careful selection of the secondary antibody and thorough wash steps minimize this issue, but it’s an inherent limitation of the two-antibody format that direct ELISA avoids entirely.
Indirect ELISA vs. Other ELISA Formats
Four main ELISA formats exist: direct, indirect, sandwich, and competitive. Each has a niche. Direct ELISA is simpler and faster but less sensitive. Sandwich ELISA uses two antibodies that bind different parts of the same antigen, making it highly specific for detecting antigens (rather than antibodies) in complex samples. Competitive ELISA measures how much a sample inhibits a known antibody-antigen interaction, useful when the target molecule is small.
Indirect ELISA occupies a sweet spot for antibody detection: it’s more sensitive than direct ELISA thanks to signal amplification, more cost-effective because secondary antibodies are reusable across many experiments, and straightforward enough for high-throughput screening. Its main disadvantage is the extra step, which adds time and an additional source of potential non-specific binding. For most antibody-detection applications in clinical and research settings, that tradeoff is well worth it.